Literature DB >> 2857715

A new mechanism for regulation of tyrosine 3-monooxygenase by end product and cyclic AMP-dependent protein kinase.

S Okuno, H Fujisawa.   

Abstract

Tyrosine 3-monooxygenase activity of the crude extract from rat striatum had a sharp pH optimum at pH 5.4 and showed almost no activity at or above pH 7. When the crude extract was partially purified by pH precipitation and chromatography on DEAE-cellulose, the enzyme showed a high activity in the pH range of 5.8 to 7.4. Incubation of the partially purified enzyme with catecholamines such as dopamine, norepinephrine, and epinephrine resulted in a remarkable decrease in the enzyme activity, as assayed at a neutral pH. This suppression of the enzyme activity by catecholamines differed from the well-known feedback inhibition which is competitive with respect to the pterin cofactor; the former occurred at a very much lower concentration of catecholamines even in the presence of a near-saturating concentration of a pterin cofactor, and the former was a time-dependent reaction. The enzyme, the activity of which had been suppressed by the incubation with dopamine, was remarkably activated by the incubation with the catalytic subunit of cyclic AMP-dependent protein kinase in the presence of an ATP-generating system. These results suggest that the activity of tyrosine 3-monooxygenase may be suppressed by its end products in a normal state and it may be stimulated by cyclic AMP-dependent protein kinase as occasion demands.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Regulation of recombinant rat tyrosine hydroxylase by dopamine.

Authors:  P Ribeiro; Y Wang; B A Citron; S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

2.  Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells.

Authors:  Ichiro Kawahata; Hirofumi Tokuoka; Hasan Parvez; Hiroshi Ichinose
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 3.  The human tyrosine hydroxylase gene.

Authors:  T Nagatsu
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

Review 4.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

5.  Deletion mutagenesis of rat PC12 tyrosine hydroxylase regulatory and catalytic domains.

Authors:  P Ribeiro; Y Wang; B A Citron; S Kaufman
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

6.  Regulation of N-terminus-deleted human tyrosine hydroxylase type 1 by end products of catecholamine biosynthetic pathway.

Authors:  A Ota; S Yoshida; T Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Partial biopterin deficiency disturbs postnatal development of the dopaminergic system in the brain.

Authors:  Daigo Homma; Chiho Sumi-Ichinose; Hirofumi Tokuoka; Kazuhisa Ikemoto; Takahide Nomura; Kazunao Kondo; Setsuko Katoh; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

8.  Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40.

Authors:  K K Andersson; C Vassort; B A Brennan; L Que; J Haavik; T Flatmark; F Gros; J Thibault
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

9.  Mutant torsinA interacts with tyrosine hydroxylase in cultured cells.

Authors:  C A O'Farrell; K L Martin; M Hutton; M B Delatycki; M R Cookson; P J Lockhart
Journal:  Neuroscience       Date:  2009-09-15       Impact factor: 3.590

10.  Activation of striatal tyrosine hydroxylase by in vivo electrical stimulation: comparison with cyclic AMP-mediated activation.

Authors:  T L Thompson; K A Colby; R L Patrick
Journal:  Neurochem Res       Date:  1990-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.